Hydroxychloroquine

Category

Major Clinical Trial in Sub-Saharan Africa (ANTICOV) to Study Hydroxychloroquine & Other Repurposed Treatments Targeting Early Onset COVID-19

An international network of research institutions and thirteen African nations have formed an alliance to conduct the largest COVID-19 clinical trial of its kind in Africa with an emphasis on investigating treatment options for mild and moderate cases at onset of...

University of Washington & Bill & Melinda Gates Foundation Study Leads to Conclusion: Hydroxychloroquine Not Effective in Preventing SARS-CoV-2 Infection

A recent study out of University of Washington School of Medicine in Seattle further weakens the case for hydroxychloroquine as a means to prevent SARS-CoV-2 infection. That is, based on a randomized, controlled trial, those individuals taking hydroxychloroquine while...

University of Kansas Medical Center Goes All Out in Research Contributing to Beating COVID-19 and Exiting the Pandemic

University of Kansas Medical Center (KUMC) joined the ACTIV-2 clinical trial recently, targeting those patients diagnosed with mild COVID-19 symptoms in a quest to determine how the advanced monoclonal antibody-based product developed by Eli Lilly, LY-COV555, can help...

A Political Ping Pong: Duke HERO Study Still Pursuing Question Whether Hydroxychloroquine a Potential Prophylaxis to COVID-19

Meet Michael Waxman, a physician from Kansas City and participant in one of the largest hydroxychloroquine clinical trials in the United States. He also happens to have the honor of being the study’s “truest guinea pig” doing it “gladly and “without reservation.” The...

Pin It on Pinterest